Investigation of the Effect of PEG Detoxification on Diphtheria Vaccine

سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 36

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_ARCHRAZI-77-2_029

تاریخ نمایه سازی: 6 دی 1402

چکیده مقاله:

Immunization has been considered a successful global health program that saves many persons’ lives each year. The vaccines reduce the risk of getting the disease by building immunity in the body. Therefore, the constant availability of essential vaccines is an important factor in community health. One of the most important vaccines is the diphtheria vaccine, which is usually used as Multivalent diphtheria-tetanus-pertussis (DTP) combination vaccines. The production of this vaccine takes about ۴۵ days, from the initial bacterial culture to the end of toxin production. However, the production of this vaccine can be optimized in case the production stages are carried out under normal conditions. In this study, a significant amount of impurities was removed after washing with phosphate buffer saline, and the toxin was then purified by Sephadex G-۵۰. In this method, the toxin was concentrated to be stored in a smaller space (this removes the concerns for the provision of a suitable space). Another problem with the diphtheria vaccine is that it is reversible after detoxification of the toxin using formaldehyde. For this reason, it is suggested to use MPEG for detoxification, which will produce more stable covalent bonds between PEG and the first type of amine groups in the toxin chain. Tests were performed to evaluate factors, such as in vivo cytotoxicity, lack of edemas formation, the neutralizing activity of serum from guinea pigs immunized with the diphtheria toxoid inactivated with MPEG, and the immunogenic activity of the purified and modified toxin. Comparison of this PEG detoxification toxoid with the standard toxoid produced in Razi Vaccine and Serum Institution, Karaj, Iran, showed that washing with PBS and purification with Sephadex G-۵۰ was an efficient method. The stability and reversibility of the toxoid approved by MPEG were acceptable. Therefore, the results of animal tests showed that the obtained product was stable and caused no wound or necrosis in the tested animals.

نویسندگان

T Hesari

Imam Khomeini International University, Qazvin, Iran

F Tahoori

Department of Human Bacterial vaccine, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran

A Nazari

Department of Proteomics-Biochemistry, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran

Z Salehi Najafabadi

Department of Human Bacterial vaccine, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran

M Samianifard

Department of Proteomics-Biochemistry, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran

A Faramarzi

Department of Human Bacterial vaccine, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran

M Soleimani

Imam Khomeini International University, Qazvin, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Vani S. Diphtheria IAP Textbook of Vaccines: Jaypee Brother Medical ...
  • Pappenheimer A, Germanier R. Diphtheria. Bacterial vaccines: Academic Press Inc; ...
  • Paliwal R, London E. Comparison of the conformation, hydrophobicity, and ...
  • Aggerbeck H, Heron I. Detoxification of diphtheria and tetanus toxin ...
  • Alconcel SNS, Baas AS, Maynard HD. FDA-approved poly(ethylene glycol)–protein conjugate ...
  • Bre LP, Zheng Y, Pego AP, Wang W. Taking tissue ...
  • Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. ...
  • Jevsevar S, Kunstelj M, Porekar VG. PEGylation of therapeutic proteins. ...
  • Lawrence PB, Gavrilov Y, Matthews SS, Langlois MI, Shental-Bechor D, ...
  • Bourne T, Fossati G, Nesbitt A. A PEGylated Fab' fragment ...
  • Mishra P, Nayak B, Dey RK. PEGylation in anti-cancer therapy: ...
  • Topf JM. CERA: third-generation erythropoiesis-stimulating agent. Expert Opin Pharmacother. ۲۰۰۸;۹(۵):۸۳۹-۴۹ ...
  • Pfister D, Bourgeaux E, Morbidelli M. Kinetic modeling of protein ...
  • VdL-Guideline. VdL-Guideline on Decorative Coatings Germany: German Paint and Printing ...
  • Zou Alfagharian H, Mohammadpour N. Study on diphtheria toxin purification: ...
  • He F. BCA (Bicinchoninic Acid) Protein Assay. Bio-protocol. ۲۰۱۱;۱(۵):۴۴ ...
  • Rappuoli R, Perugini M, Marsili I, Fabbiani S. Rapid purification ...
  • Moyner K, Christiansen G. Comparison of gel filtration and ammonium ...
  • Mekada E, Senoh H, Iwamoto R, Okada Y, Uchida T. ...
  • نمایش کامل مراجع